Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F11 | P03951 | 20/20 | 0.45 |
| ▸ | KLKB1 | P03952 | 18/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30995011 | 0.85 | F11 (0.43) | F11KLKB1CYP3A4 | |
| SCHEMBL24633365 | 0.85 | F11 (0.43) | F11KLKB1CYP3A4 | |
| SCHEMBL24633397 | 0.83 | F11 (0.43) | F11KLKB1CYP3A4 | |
| SCHEMBL16971567 | 0.83 | F11 (0.43) | F11KLKB1CYP3A4 | |
| SCHEMBL24633281 | 0.82 | F11 (0.50) | F11KLKB1CYP3A4 | |
| SCHEMBL31544734 | 0.82 | F11 (0.42) | F11KLKB1CYP3A4 | |
| SCHEMBL30995026 | 0.81 | F11 (0.44) | F11KLKB1 | |
| SCHEMBL29227917 | 0.79 | CNR1 (0.42) | F11KLKB1CYP3A4 | |
| SCHEMBL30995053 | 0.77 | F11 (0.45) | F11KLKB1 | |
| SCHEMBL29227939 | 0.77 | F11 (0.45) | F11KLKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4737457-A1 | POLYSUBSTITUTED MACROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Shenzhen Salubris Pharmaceuticals Co., Ltd. (CN) | 2026-05-06 | — | — | EP | disclosed |
| CN-119894901-A | Polysubstituted macrocyclic compound, and preparation method and application thereof | 深圳信立泰药业股份有限公司 | 2025-04-25 | — | — | CN | disclosed |
| WO-2025002297-A1 | POLYSUBSTITUTED MACROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 深圳信立泰药业股份有限公司 | 2025-01-02 | — | — | WO | disclosed |